Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-14

Clinical Trial Update: A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD) [NA]

View source ↗

Summary

A completed clinical trial evaluated different methods to measure the effect of atomoxetine on impulsive behavior in young adults with Attention Deficit Hyperac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED | Results posted: 2025-11-14